Imatinib D4(Synonyms: STI571 D4; CGP-57148B D4)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Imatinib D4 (Synonyms: STI571 D4; CGP-57148B D4) 纯度: ≥99.0%

Imatinib D4 (STI571 D4) 是 Imatinib (STI571) 的氘代物。Imatinib 是一种口服生物可用的酪氨酸激酶抑制剂，可选择性抑制 BCR/ABL，v-Abl，PDGFR，c-kit 激酶活性。

Imatinib D4 Chemical Structure

CAS No. : 1134803-16-9

规格	价格	是否有货
1 mg	￥2500	In-stock
5 mg	￥5500	In-stock
10 mg		询价
50 mg		询价

* Please select Quantity before adding items.

生物活性

Imatinib D4 (STI571 D4) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity^[1]^[2].

分子量

497.63

Formula

C₂₉H₂₇D₄N₇O

CAS 号

1134803-16-9

中文名称

伊马替尼 D4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

参考文献

[1]. Heinrich MC, et al. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood. 2000 Aug 1;96(3):925-32.

[2]. Guida T, et al. Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants. Clin Cancer Res. 2007 Jun 1;13(11):3363-9.

[3]. Coleman CM, et al, Frieman MB. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion. J Virol. 2016;90(19):8924‐8933. Published 2016 Sep 12.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务